367 related articles for article (PubMed ID: 3106703)
1. [Treatment of Pseudomonas aeruginosa infection in burn patients].
Litovchenko PP; Nazarchuk LV; Degtiar NV; Abu-el-Khava MI; Gaĭduk VI
Klin Khir (1962); 1987; (3):24-7. PubMed ID: 3106703
[No Abstract] [Full Text] [Related]
2. [Drug sensitivity of Pseudomonas aeruginosa isolated from burn wounds during 1985/1986 and its serologic types].
Ziółkowski G; Dudzińska G; Sakiel S
Pol Tyg Lek; 1988 Dec; 43(49):1596-8. PubMed ID: 3151376
[No Abstract] [Full Text] [Related]
3. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
Arya SC; Agarwal N; Agarwal S
Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
[No Abstract] [Full Text] [Related]
4. The efficacy of honey in inhibiting strains of Pseudomonas aeruginosa from infected burns.
Cooper RA; Halas E; Molan PC
J Burn Care Rehabil; 2002; 23(6):366-70. PubMed ID: 12432313
[TBL] [Abstract][Full Text] [Related]
5. [Ways of increasing the effectiveness of antibacterial drugs in the treatment of pseudomonas infection in burns].
Moroz AF; Vinogradova OI; Bekbergenov BM; Brodinova NS; Antsiferova NG
Khirurgiia (Mosk); 1976 Jun; (6):81-8. PubMed ID: 827653
[No Abstract] [Full Text] [Related]
6. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Naqvi SH; Naqvi SH
S Afr J Surg; 2013 Oct; 51(4):151-2. PubMed ID: 24209702
[No Abstract] [Full Text] [Related]
7. Pseudomonas aeruginosa burn wound infection in a dedicated paediatric burns unit.
Coetzee E; Rode H; Kahn D
S Afr J Surg; 2013 May; 51(2):50-3. PubMed ID: 23725892
[TBL] [Abstract][Full Text] [Related]
8. Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Barnea Y; Carmeli Y; Neville LF; Kahel-Reifer H; Eren R; Dagan S; Navon-Venezia S
Burns; 2009 May; 35(3):390-6. PubMed ID: 18951715
[TBL] [Abstract][Full Text] [Related]
9. Arginine Is a Critical Substrate for the Pathogenesis of
Everett J; Turner K; Cai Q; Gordon V; Whiteley M; Rumbaugh K
mBio; 2017 Mar; 8(2):. PubMed ID: 28292986
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas infections in Tohid Burn Center, Iran.
Rastegar Lari A; Bahrami Honar H; Alaghehbandan R
Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062
[TBL] [Abstract][Full Text] [Related]
11. Infection in burns.
Settle JA
J Hosp Infect; 1985 Sep; 6 Suppl B():19-29. PubMed ID: 2865307
[No Abstract] [Full Text] [Related]
12. The impact of the types of microorganisms isolated from blood and wounds on the results of treatment in burn patients with sepsis.
Glik J; Kawecki M; Gaździk T; Nowak M
Pol Przegl Chir; 2012 Jan; 84(1):6-16. PubMed ID: 22472489
[TBL] [Abstract][Full Text] [Related]
13. [An experimental validation of the use of levomycetin preparations for the treatment of burns infected with Pseudomonas aeruginosa].
Tkachenko VL; Tsyganenko AIa; Liapunov NA; Bezuglaia EP; Minukhin VV
Mikrobiol Z; 1999; 61(3):30-6. PubMed ID: 10483230
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of different types of honey against clinical and environmental isolates of Pseudomonas aeruginosa.
Mullai V; Menon T
J Altern Complement Med; 2007 May; 13(4):439-41. PubMed ID: 17532737
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Mannosidase and Trypsin Enzymes Effects on Biofilm Production of Pseudomonas aeruginosa Isolated from Burn Wound Infections.
Banar M; Emaneini M; Satarzadeh M; Abdellahi N; Beigverdi R; Leeuwen WB; Jabalameli F
PLoS One; 2016; 11(10):e0164622. PubMed ID: 27736961
[TBL] [Abstract][Full Text] [Related]
16. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
Fu KP; Vince T; Hung PP; Gregory JF
Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
[TBL] [Abstract][Full Text] [Related]
17. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
18. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine].
Denys A; Grzybowski A; Białek J; Horoszewicz-Małafiej A; Korczak E; Kowalska M; Małafiej E; Szydłowska T
Med Dosw Mikrobiol; 1983; 35(2):155-62. PubMed ID: 6423917
[No Abstract] [Full Text] [Related]
19. Pseudomonas aeruginosa bacteraemia in burns patients: Risk factors and outcomes.
Mahar P; Padiglione AA; Cleland H; Paul E; Hinrichs M; Wasiak J
Burns; 2010 Dec; 36(8):1228-33. PubMed ID: 20965109
[TBL] [Abstract][Full Text] [Related]
20. Experimental burn wound sepsis: variations in response to topical agents.
Krizek TJ; Cossman DV
J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
[No Abstract] [Full Text] [Related]
[Next] [New Search]
